On Thursday, UnitedHealth Group (NYSE: UNH) named Tim Noel, the head of its Medicare business, to the top job at
1 year ago
On Wednesday, Abbott Laboratories (NYSE: ABT) forecast 2025 profit that came in line with Wall Street estimates as it expects
Johnson & Johnson (NYSE: JNJ), fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular (NASDAQ: ITCI), reported fourth-quarter
Medtronic (NYSE: MDT) will appoint Renault’s finance chief Thierry Pieton as its chief financial officer effective March 3, the medical
WASHINGTON – On Friday, the U.S. Justice Department said it has filed a lawsuit alleging that pharmacy chain operator Walgreens
Novo Nordisk’s (NYSE: NVO) blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare
AstraZeneca (NASDAQ: AZN) has overhauled its local management in China, replacing Michael Lai with Alex Lin as the country’s general
WASHINGTON – Novartis (NYSE: NVS) won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker
COPENHAGEN – Danish businesses are concerned about a possible trade conflict with the United States over Greenland, a major lobby
On Thursday, UnitedHealth Group (NYSE: UNH) CEO Andrew Witty said that healthcare in the U.S. needs to be “less confusing,
WASHINGTON – A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals’ launch of a generic version of Novartis’ (NYSE: NVS)
Gilead Sciences (NASDAQ: GILD) and the U.S. government have settled a billion-dollar patent dispute over Gilead’s HIV prevention drugs Truvada
